GlobeImmune Inc. announced earnings results for the quarter and nine months ended September 30, 2014. For the quarter, the company reported net loss of $6.4 million compared to $0.7 million a year ago.

For the nine months the company reported net loss of $14.5 million compared to $1.2 million a year ago. The increase in the net losses was primarily due to non-cash interest expense and early retirement associated with convertible notes and fair-value adjustments of warrants. These non-cash expenses terminated upon closing of the initial public offering.